London, UK, 14 April, 2014 - On 26 February 2014, Lombard Medical (AIM: LMT), published a circular setting out the Board of Directors' recommendations to, inter alia, reorganise the Lombard Medical Group pursuant to a Court approved scheme of arrangement (the "Scheme") for Lombard Medical to become a directly-owned subsidiary of Lombard Medical, Inc ("LM, Inc").
On 18 March 2014, the Company announced that the Court Meeting held on that day approved the proposed Scheme as well as a revision to the indicative timetable published in the Circular.
On 11 April 2014 the Company announced a further revision to the indicative timetable published in the Circular, as a result of the timetable of the IPO of LM, Inc shares on the NASDAQ Global Market being extended due to current adverse US stock market conditions.
A Court Hearing was held today and the Court granted an adjournment until 29 April 2014.
The timetable is currently being reviewed and the Company will notify shareholders of the revised timetable, including details of the adjourned Court Hearing, in due course through a Regulatory Information Service and by notice on the Company's website.
This press release and the information it contains is not for publication or distribution, directly or indirectly, in or into the United States. This press release is not intended to, and does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.